News Boost for mRNA as Moderna to acquire OriCiro for $85 million Biotech Moderna, Inc. and OriCiro Genomics K.K.
News PTC stung by FDA decision not to approve rare disease drug It looks like PTC will have to carry out another trial of its drug for Friedreich ataxia before the FDA will consider approval.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
